Literature DB >> 10229545

Some immunological properties of lipopolysaccharide from Acinetobacter baumannii.

Apolinaria GARCíA, Fernando Salgado, Henry Solar, Carlos L GONZáLEZ, RAüL Zemelman, Angel OñTATE.   

Abstract

Acinetobacter baumannii, mainly biotype 9, is an important nosocomial opportunist pathogen in Chile and other countries. The biological basis of its virulence and prevalence is still unknown. As lipopolysaccharide (LPS) is often associated with virulence, some biological properties of purified LPS from seven nosocomial isolates, comprising four isolates of A. baumannii biotype 9, two isolates of biotype 8 and one isolate of biotype 1, were investigated. LPS was extracted and purified from each isolate by the hot phenol-water method, and its ability to elicit a mitogenic response and to induce the synthesis of a tumour necrosis factor (TNF-alpha) in mouse spleen cells was determined. Activity was evaluated in vivo by determining the splenic index in comparison with LPS from Salmonella Typhimurium. All seven LPS samples were mitogenic on the basis of cellular proliferation experiments and six induced synthesis of TNF-alpha. Similar results were obtained in in-vivo experiments in which LPS induced spleen cell growth, as shown by determination of the splenic index. These results suggest that the LPS of A. baumannii might contribute to the pathogenic properties of this species.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229545     DOI: 10.1099/00222615-48-5-479

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  8 in total

1.  Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection.

Authors:  Brittany L Mortensen; Eric P Skaar
Journal:  Cell Microbiol       Date:  2012-06-14       Impact factor: 3.715

Review 2.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.

Authors:  Ignasi Roca; Paula Espinal; Xavier Vila-Farrés; Jordi Vila
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

4.  Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources.

Authors:  Azam F Tayabali; Kathy C Nguyen; Philip S Shwed; Jennifer Crosthwait; Gordon Coleman; Verner L Seligy
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

Review 5.  Host Innate Immune Responses to Acinetobacter baumannii Infection.

Authors:  Wangxue Chen
Journal:  Front Cell Infect Microbiol       Date:  2020-09-14       Impact factor: 5.293

6.  Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis.

Authors:  Lin Lin; Brandon Tan; Paul Pantapalangkoor; Tiffany Ho; Beverlie Baquir; Andrew Tomaras; Justin I Montgomery; Usa Reilly; Elsa G Barbacci; Kristine Hujer; Robert A Bonomo; Lucia Fernandez; Robert E W Hancock; Mark D Adams; Samuel W French; Virgil S Buslon; Brad Spellberg
Journal:  MBio       Date:  2012-10-02       Impact factor: 7.867

Review 7.  Acinetobacter baumannii Infection and IL-17 Mediated Immunity.

Authors:  Zihe Yan; Junjun Yang; Renjing Hu; Xichi Hu; Kong Chen
Journal:  Mediators Inflamm       Date:  2016-02-09       Impact factor: 4.711

Review 8.  The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections.

Authors:  María Guadalupe García-Patiño; Rodolfo García-Contreras; Paula Licona-Limón
Journal:  Front Immunol       Date:  2017-04-12       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.